Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,247.60
(
0.48%
)
Dow Jones
46,993.26
(
0.00%
)
Brent Oil
101.78
(
1.12%
)
Bitcoin
72,748.48
(
-1.61%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biotech jim

Send PM Follow Ignore
Followers 49
Posts 644
Boards Moderated 0
Alias Born 05/02/2011

biotech jim

Re: DewDiligence post# 143791

Wednesday, 06/13/2012 2:50:20 PM

Wednesday, June 13, 2012 2:50:20 PM

Post# of 257253
Due to the 12 month study run by MRK with very good results, suvo should get approved for chronic use. The GABAergics do not have such a label, so this should be an angle for reimbursement as well.

I just listened to the MRK conf call, so I will comment on what I heard in a subsequent post.

BJ
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now